InvestorsHub Logo
Followers 13
Posts 1022
Boards Moderated 0
Alias Born 07/19/2013

Re: None

Wednesday, 11/23/2022 1:33:22 PM

Wednesday, November 23, 2022 1:33:22 PM

Post# of 141
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.

-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings

Outstanding Shares: 1.01 Billion
Float : ~ 750 Million

Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm

ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?

Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderal
l


>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.